Showing 251-260 of 19172 results for "".
Initiating Insulin Therapy for Type 2 Diabetes
https://reachmd.com/programs/diabetes-discourse/initiating-insulin-therapy-for-type-2-diabetes/5569/Initiating insulin therapy for type 2 patients provides its own set of challenges and opportunities. New insulin preparations and a better understanding of insulin physiology may provide physicians more options in effectively tailoring insulin therapy to the needs of their patients. Join host Dr. StNew AACE Guidelines for Treating Type 2 Diabetes
https://reachmd.com/programs/diabetes-discourse/new-aace-guidelines-for-treating-type-2-diabetes/4827/The new American Association of Clinical Endocrinologists (AACE) guidelines represent a major shift in the way type 2 diabetes is treated. An emphasis on hypoglycemia, adherence to therapy and new medications are included in this new algorithm. Join host Dr. Steven Edelman and his guest, president-eTrends in the Treatment of Type 1 diabetes
https://reachmd.com/programs/clinicians-roundtable/trends-in-the-treatment-of-type-1-diabetes/327/Dr. Laffel, chief of the Pediatric and Adolescent Section at Joslin Clinic and an Investigator in the section on Genetics and Epidemiology at Joslin Diabetes Center as well as an Associate Professor of Pediatrics at Harvard Medical School discusses her latest research published in the Journal of PedParents Live into Their 90's at Lower Risk for Type 2 Diabetes
https://reachmd.com/programs/diabetes-discourse/parents-live-into-their-90s-at-lower-risk-for-type-2-diabetes/13672/This research shows that patients whose parents live into their 90s are at lower risk for type 2 diabetes—and so are their spouses.Neonatal Diabetes: A Special Case of Type 1 Diabetes
https://reachmd.com/programs/clinicians-roundtable/neonatal-diabetes-a-special-case-of-type-1-diabetes/1690/Dr. Louis Philipson from the University of Chicago joins host Dr. Danny Petrasek to discuss Neonatal Diabetes and the clinical trials behind discovering treatments for this disease.Clinical Trials to Cure Type 1 Diabetes With Generic Drugs
https://reachmd.com/programs/focus-on-diabetes/clinical-trials-to-cure-type-1-diabetes-with-generic-drugs/3853/The first clinical trial using generic drugs to cure type 1 diabetes has created quite a buzz in the diabetic patient and physician communities. Join host Dr.Bruce Bloom and his guest, Dr. Denise L. Faustman, associate professor of medicine at Harvard Medical School and director of the ImmunobiologyBehind the Screens: Innovations in Type 1 Diabetes Clinical Trials—From Immunomodulation to Screening Strategies and Advanced Cell Therapies
https://reachmd.com/programs/cme/behind-the-screens-innovations-in-type-1-diabetes-clinical-trialsfrom-immunomodulation-to-screening-strategies-and-advanced-cell-therapies/39701/Behind the Screens: Innovations in Type 1 Diabetes Clinical Trials—From Immunomodulation to Screening Strategies and Advanced Cell TherapiesUpdated Target Blood Sugar Levels for Type 2 Diabetes Patients
https://reachmd.com/programs/what-your-patients-are-talking-about/updated-target-blood-sugar-levels-type-2-diabetes-patients/7387/According to a report in the New England Journal of Medicine, doctors now have updated targets for lowering blood sugar in their Type 2 diabetes patients.Prova Education -- Improving Treatment for Type 2 Diabetes: Overcoming Barriers to Optimal Care, Part 3
https://reachmd.com/programs/grand-rounds-nation/prova-education-improving-treatment-for-type-2-diabetes-overcoming-barriers-to-optimal-care-part-3/6566/This program will address the increasing prevalence of overweight, obese and type 2 diabetes conditions in our patient population. Physicians and healthcare professionals are confronted with multiple treatment and management challenges for type 2 diabetes. Treatment goals and care-delivery systems oProva Education -- Improving Treatment for Type 2 Diabetes: Overcoming Barriers to Optimal Care, Part 2
https://reachmd.com/programs/grand-rounds-nation/prova-education-improving-treatment-for-type-2-diabetes-overcoming-barriers-to-optimal-care-part-2/6565/This program will address the increasing prevalence of overweight, obese and type 2 diabetes conditions in our patient population. Physicians and healthcare professionals are confronted with multiple treatment and management challenges for type 2 diabetes. Treatment goals and care-delivery systems o